189 related articles for article (PubMed ID: 36847016)
1. Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay.
Arlinghaus R; Iba M; Masliah E; Cookson MR; Landeck N
J Parkinsons Dis; 2023; 13(2):255-270. PubMed ID: 36847016
[TBL] [Abstract][Full Text] [Related]
2. A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.
Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OM; Halliday G; Kirik D
Mol Neurodegener; 2016 Aug; 11(1):61. PubMed ID: 27549140
[TBL] [Abstract][Full Text] [Related]
3. Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies.
Fayyad M; Majbour NK; Vaikath NN; Erskine D; El-Tarawneh H; Sudhakaran IP; Abdesselem H; El-Agnaf OMA
Neurosci Lett; 2020 Apr; 725():134899. PubMed ID: 32156613
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
Elfarrash S; Jensen NM; Ferreira N; Schmidt SI; Gregersen E; Vestergaard MV; Nabavi S; Meyer M; Jensen PH
PLoS One; 2021; 16(10):e0252635. PubMed ID: 34613964
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity.
Lashuel HA; Mahul-Mellier AL; Novello S; Hegde RN; Jasiqi Y; Altay MF; Donzelli S; DeGuire SM; Burai R; Magalhães P; Chiki A; Ricci J; Boussouf M; Sadek A; Stoops E; Iseli C; Guex N
NPJ Parkinsons Dis; 2022 Oct; 8(1):136. PubMed ID: 36266318
[TBL] [Abstract][Full Text] [Related]
6. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.
Koss DJ; Erskine D; Porter A; Palmoski P; Menon H; Todd OGJ; Leite M; Attems J; Outeiro TF
Acta Neuropathol Commun; 2022 Jul; 10(1):98. PubMed ID: 35794636
[TBL] [Abstract][Full Text] [Related]
7. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders.
Altay MF; Liu AKL; Holton JL; Parkkinen L; Lashuel HA
Acta Neuropathol Commun; 2022 Nov; 10(1):163. PubMed ID: 36371251
[TBL] [Abstract][Full Text] [Related]
8. Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.
van der Gaag BL; Deshayes NAC; Breve JJP; Bol JGJM; Jonker AJ; Hoozemans JJM; Courade JP; van de Berg WDJ
Acta Neuropathol; 2024 Jan; 147(1):14. PubMed ID: 38198008
[TBL] [Abstract][Full Text] [Related]
9. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
Oueslati A
J Parkinsons Dis; 2016; 6(1):39-51. PubMed ID: 27003784
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease.
Tenreiro S; Reimão-Pinto MM; Antas P; Rino J; Wawrzycka D; Macedo D; Rosado-Ramos R; Amen T; Waiss M; Magalhães F; Gomes A; Santos CN; Kaganovich D; Outeiro TF
PLoS Genet; 2014 May; 10(5):e1004302. PubMed ID: 24810576
[TBL] [Abstract][Full Text] [Related]
11. Investigating the presence of doubly phosphorylated α-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.
Fayyad M; Erskine D; Majbour NK; Vaikath NN; Ghanem SS; Sudhakaran IP; Abdesselem H; Lamprokostopoulou A; Vekrellis K; Morris CM; Attems J; El-Agnaf OMA
Brain Pathol; 2020 Jul; 30(4):831-843. PubMed ID: 32324926
[TBL] [Abstract][Full Text] [Related]
12. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.
Roberts RF; Wade-Martins R; Alegre-Abarrategui J
Brain; 2015 Jun; 138(Pt 6):1642-57. PubMed ID: 25732184
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.
Ghanem SS; Majbour NK; Vaikath NN; Ardah MT; Erskine D; Jensen NM; Fayyad M; Sudhakaran IP; Vasili E; Melachroinou K; Abdi IY; Poggiolini I; Santos P; Dorn A; Carloni P; Vekrellis K; Attems J; McKeith I; Outeiro TF; Jensen PH; El-Agnaf OMA
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2109617119. PubMed ID: 35353605
[TBL] [Abstract][Full Text] [Related]
14. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
[TBL] [Abstract][Full Text] [Related]
15. Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.
Walker DG; Lue LF; Adler CH; Shill HA; Caviness JN; Sabbagh MN; Akiyama H; Serrano GE; Sue LI; Beach TG;
Exp Neurol; 2013 Feb; 240():190-204. PubMed ID: 23201181
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
[TBL] [Abstract][Full Text] [Related]
17. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
Lashuel HA
Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
[TBL] [Abstract][Full Text] [Related]
18. Ubiquilin-2 regulates pathological alpha-synuclein.
Sandoval-Pistorius SS; Gerson JE; Liggans N; Ryou JH; Oak K; Li X; Negron-Rios KY; Fischer S; Barsh H; Crowley EV; Skinner ME; Sharkey LM; Barmada SJ; Paulson HL
Sci Rep; 2023 Jan; 13(1):293. PubMed ID: 36609661
[TBL] [Abstract][Full Text] [Related]
19. SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening.
Henderson-Smith A; Chow D; Meechoovet B; Aziz M; Jacobson SA; Shill HA; Sabbagh MN; Caviness JN; Adler CH; Driver-Dunckley ED; Beach TG; Yin H; Dunckley T
PLoS One; 2013; 8(10):e77711. PubMed ID: 24204929
[TBL] [Abstract][Full Text] [Related]
20. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.
Ruffmann C; Bengoa-Vergniory N; Poggiolini I; Ritchie D; Hu MT; Alegre-Abarrategui J; Parkkinen L
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):722-736. PubMed ID: 29676021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
